Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 21, 2016; 22(47): 10304-10315
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10304
Published online Dec 21, 2016. doi: 10.3748/wjg.v22.i47.10304
Table 7 Clinical trials of fecal microbial transplant for pediatric inflammatory bowel disease (registered through clinicaltrials.gov)
Location | Trial number | Diagnosis | Age (yr) | Donor | FMT route | Interven-tion | Protocol |
Hamilton, | NCT02487238 | UC | 6-17 | Anonymous | Enema | FMT, Saline | Retention enema; 2 × weekly × 6 wk; 33-wk follow up |
Canada | Randomized Single Blinded | ||||||
California, United States | NCT02291523 | UC | 7-2 | Accepting volunteers | Colonoscopic | FMT, Saline | Patients on high-dose 5-ASA; 1 × colonoscopic administration; 12-mo follow up |
Randomized Double Blinded | |||||||
Chongqing, China | NCT02335281 | UC/CD | 16-70 | Not specified | Nasojejunal | FMT, Mesalazine | Single nasojejunal administration; 1-yr follow up |
Randomized Single Blinded | |||||||
Texas, United States | NCT01947101 | UC | 12-20 | Anonymous | Colonoscopic /Enema | FMT | Colonoscopic administration for first treatment; subsequent periodic treatments over 1-year with enema administration |
Pennsylvania, United States | NCT02108821 | UC/CD | 2-22 | Family member | Colonoscopic | Open Label | Fresh stool sample; 1 ×, 1-h duration; 6-mo follow up |
FMT | |||||||
Michigan, United States | NCT01560819 | UC/CD | 7-21 | Family member | Enema | Open Label | 1-hour retention enema; daily × 5 d; 6-mo follow up |
FMT | |||||||
Jerusalem, Israel; | NCT02033408 | UC/CD | 2-75 | Not specified | Not specified | Open Label | Secondary treatment for antibiotic, corticosteroid failures; 3-yr follow up |
Toronto, Canada; | FMT | ||||||
Helsinki, Finland; | Open Label | ||||||
Napoli, Italy; | |||||||
Rome, Italy; | |||||||
Krakow, Poland; | |||||||
Malaga, Spain | |||||||
Michigan, United States | NCT01560819 | UC/CD | 7-21 | Family member/ | Enema | FMT | Retention enema; Administered daily × 5 d; 6-mo follow up |
Chosen by family | Open Label | ||||||
Turku, Finland | NCT01961492 | UC | 1-75 | Anonymous | Colonoscopic | FMT | Single colonoscopic administration; 1-yr follow up |
Open Label | |||||||
Jiangsu, China | NCT01793831 | UC/CD | 10-70 | Not specified | Nasogastric | FMT | Single nasogastric administration; 12-mo follow up |
Shaanxi, China | Open Label | ||||||
Jiangsu, China | NCT01790061 | UC | 10-70 | Not specified | Duodenal (gastroscopic) | FMT | 1-mo follow up |
Shaanxi, China | Open Label | Fresh, or frozen FMT administered via gastroscope | |||||
No prior biologic, immunomodulatory, corticosteroid therapy | |||||||
Jiangsu, China | NCT02560727 | UC | 10-70 | Not specified | Colonoscopic | Not specified | 12-mo follow up |
No prior biologic, immunomodulatory, corticosteroid therapy |
- Citation: Wang AY, Popov J, Pai N. Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol 2016; 22(47): 10304-10315
- URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10304.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i47.10304